Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized, Multicenter Study of Non-Invasive Vagus Nerve Stimulation (nVNS), Cannabidiol, and Standard of Care for the Treatment of Persistent Post-Traumatic Headache in Elite Athletes

NCT07624279 is registered in ClinicalTrials.gov with American Society of Pain and Neuroscience, Inc. as lead sponsor.

NCT NCT07624279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07624279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized, Multicenter Study of Non-Invasive Vagus Nerve Stimulation (nVNS), Cannabidiol, and Standard of Care for the Treatment of Persistent Post-Traumatic Headache in Elite Athletes
Lead sponsor
American Society of Pain and Neuroscience, Inc.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
July 1, 2028
Enrollment
80 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

persistent post traumatic headache